10/15/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024
5:01 PM | Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
4:20 PM | Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
|
07/30/2024
5:00 AM | Alzamend Neuro (Filer)
| Form NT 10-K | |
07/12/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
7:52 AM | Alzamend Neuro (Filer)
| Form 424B3 | |
07/09/2024
11:15 PM | Alzamend Neuro (Filer)
| Form EFFECT | |
07/08/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2024
3:31 PM | Alzamend Neuro (Filer)
| Form S-1/A | |
06/26/2024
3:46 PM | Alzamend Neuro (Filer)
| Form S-1/A | |
06/11/2024
3:30 PM | Alzamend Neuro (Filer)
| Form DEFA14A | |
06/03/2024
3:30 PM | Alzamend Neuro (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
05/22/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2024
3:30 PM | Alzamend Neuro (Issuer)
McGrath Lynne Fahey (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
05/10/2024
4:06 PM | Alzamend Neuro (Filer)
| Form PRE 14A | |
05/10/2024
5:30 AM | Alzamend Neuro (Filer)
| Form 424B5 | |
05/09/2024
3:20 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2024
3:31 PM | Alzamend Neuro (Filer)
| Form DEFA14A | |
04/23/2024
7:00 PM | Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
4:00 PM | Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
3:30 PM | Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
3:30 PM | Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
4:27 PM | Alzamend Neuro (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/22/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
3:30 PM | Alzamend Neuro (Filer)
| Form NT 10-Q | |
03/13/2024
3:30 PM | Alzamend Neuro (Filer)
| Form PRE 14A | |
03/07/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
3:38 PM | Alzamend Neuro (Subject)
AULT MILTON C III (Filed by)
| Form SC 13D/A | |
02/02/2024
3:30 PM | Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
3:30 PM | Alzamend Neuro (Filer)
Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2024
4:20 PM | Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
4:21 PM | Alzamend Neuro (Subject)
AULT MILTON C III (Filed by)
| Form SC 13D/A | |
01/09/2024
3:30 PM | Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2023
3:30 PM | Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
3:30 PM | Alzamend Neuro (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
“Sleeping Giant” Crypto Set to Explode… (Ad) What if I told you there's a crypto that could make Bitcoin look like small change?
We're looking at potential returns that could rewrite your financial future.
 Click here to discover our #1 crypto pick before it's too late |
Free ALZN Stock Alerts